Strides

Our pioneering initiatives have delivered consistently for our shareholders.

Shareholder Information

Our experience has enabled us to foresee emerging trends, successfully execute strategies and deliver on stakeholder aspirations.

Vision and Mission

Headquartered in India, Strides Pharma Science Limited is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world's largest manufacturers of soft gelatin capsules.

With world-class manufacturing facilities, an innovative R&D hub in Bangalore and a robust commercial platform to market products globally, Strides has earned a reputation for building and scaling profitable businesses in a short span of time.

Read More

Attention Shareholders - holding shares in physical form

25 Sep/23	Transaction amongst wholly-owned subsidiaries
25 Sep/23	Intimation of Scheme of Arrangement pursuant to Regulation 30 of SEBI Listing Regulations
25 Sep/23	Investor call link
23 Sep/23	Strides receives USFDA approval for Icosapent Ethyl Capsules
20 Sep/23	Intimation of Board Meeting scheduled on Sept 25, 2023
15 Sep/23	Strides receives tentative USFDA approval for Dolutegravir/ Lamivudine/ Tenofovir Disproxil Fumurate tablets.
14 Sep/23	Strides receives tentative USFDA approval for Dolutegravir tablets.
09 Sep/23	Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension.
07 Sep/23	Intimation under Regulation 30 of SEBI LODR - Internal Restructuring of Strides Pharma Services Private Limited, a group entity.
Read More

25